PL2398502T3 - Kompozycje i sposoby do zapobiegania zaburzeniu rytmu serca - Google Patents

Kompozycje i sposoby do zapobiegania zaburzeniu rytmu serca

Info

Publication number
PL2398502T3
PL2398502T3 PL10744236T PL10744236T PL2398502T3 PL 2398502 T3 PL2398502 T3 PL 2398502T3 PL 10744236 T PL10744236 T PL 10744236T PL 10744236 T PL10744236 T PL 10744236T PL 2398502 T3 PL2398502 T3 PL 2398502T3
Authority
PL
Poland
Prior art keywords
compositions
methods
cardiac arrhythmia
preventing cardiac
preventing
Prior art date
Application number
PL10744236T
Other languages
English (en)
Inventor
Robert G Matheny
Beecher C Lewis
Original Assignee
Cormatrix Cardiovascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cormatrix Cardiovascular Inc filed Critical Cormatrix Cardiovascular Inc
Publication of PL2398502T3 publication Critical patent/PL2398502T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2086—IL-13 to IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2093—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
PL10744236T 2009-02-18 2010-02-17 Kompozycje i sposoby do zapobiegania zaburzeniu rytmu serca PL2398502T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15340209P 2009-02-18 2009-02-18
PCT/US2010/024441 WO2010096458A1 (en) 2009-02-18 2010-02-17 Compositions and methods for preventing cardiac arrhythmia
EP10744236.0A EP2398502B1 (en) 2009-02-18 2010-02-17 Compositions and methods for preventing cardiac arrhythmia

Publications (1)

Publication Number Publication Date
PL2398502T3 true PL2398502T3 (pl) 2016-03-31

Family

ID=42634194

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15190293T PL3000472T3 (pl) 2009-02-18 2010-02-17 Kompozycje do zapobiegania migotaniu przedsionków i komór
PL10744236T PL2398502T3 (pl) 2009-02-18 2010-02-17 Kompozycje i sposoby do zapobiegania zaburzeniu rytmu serca

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL15190293T PL3000472T3 (pl) 2009-02-18 2010-02-17 Kompozycje do zapobiegania migotaniu przedsionków i komór

Country Status (16)

Country Link
US (8) US8980296B2 (pl)
EP (2) EP2398502B1 (pl)
JP (1) JP2012518041A (pl)
KR (1) KR20120033299A (pl)
CN (1) CN102395381A (pl)
AU (1) AU2010216095B2 (pl)
BR (1) BRPI1008628A2 (pl)
CA (1) CA2752899A1 (pl)
DK (1) DK2398502T3 (pl)
ES (1) ES2553762T3 (pl)
HK (1) HK1165332A1 (pl)
IL (1) IL214706A (pl)
MX (1) MX2011008735A (pl)
PL (2) PL3000472T3 (pl)
WO (1) WO2010096458A1 (pl)
ZA (1) ZA201106165B (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072816B2 (en) * 2006-01-18 2015-07-07 Cormatrix Cardiovascular, Inc. Composition for modulating inflammation of cardiovascular tissue
US9119899B2 (en) 2006-01-18 2015-09-01 Cormatrix Cardiovascular, Inc. Method and system for treatment of cardiovascular disorders
US9532943B2 (en) * 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
WO2008109407A2 (en) 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix-derived gels and related methods
US20080279833A1 (en) 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US9283302B2 (en) 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
US9066993B2 (en) * 2007-05-10 2015-06-30 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
HUE033504T2 (en) 2008-09-30 2017-12-28 Univ California Compositions comprising a decellularized extracellular matrix extracted from cardiac tissue
US8980296B2 (en) * 2009-02-18 2015-03-17 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US8877224B2 (en) * 2009-02-18 2014-11-04 Cormatrix Cardiovascular, Inc Compositions for preventing cardiac arrhythmia
EP3888714A1 (en) 2010-07-31 2021-10-06 Cook Medical Technologies LLC Collagenous tissue pocket for an implantable medical device, and manufacturing method therefor
WO2012027514A2 (en) 2010-08-24 2012-03-01 The Regents Of The University Of California Compositions and methods for cardiac therapy
SG10201510484YA (en) * 2010-12-20 2016-01-28 Cormatrix Cardiovascular Inc A drug eluting patch for the treatment of localized tissue disease or defect
CA2832731C (en) * 2011-04-28 2020-04-14 Lifecell Corporation Method for enzymatic treatment of tissue products
US10207025B2 (en) 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US9238793B2 (en) 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
AU2012262538B2 (en) 2011-05-27 2015-09-17 Cormatrix Cardiovascular, Inc. Sterilized, acellular extracellular matrix compositions and methods of making thereof
US8895304B2 (en) 2011-12-09 2014-11-25 Acell, Inc. Hemostatic device
US20200368393A1 (en) * 2011-12-16 2020-11-26 Cormatrix Cardiovascular, Inc. Biological Formulations and Methods for Treating Cardiac Tissue and Disorders
US20200397945A1 (en) * 2011-12-16 2020-12-24 Cormatrix Cardiovascular, Inc. Biological Formulations and Methods for Treating Cardiac Tissue and Disorders
EP2869858B1 (en) 2012-07-06 2019-02-27 LifeCell Corporation Decellularized muscle matrix
EP2897689A4 (en) * 2012-09-24 2016-03-30 Cormatrix Cardiovascular Inc COMPOSITIONS AND METHODS OF TREATING ALOPEZIA
EP2897535A4 (en) * 2012-09-24 2016-06-22 Cormatrix Cardiovascular Inc INJECTION DEVICE WITH MULTIPLE NEEDLES AND SYSTEM FOR THE DISTRIBUTION OF PHARMACOLOGICAL ACTIVE SUBSTANCES TO BIOLOGICAL TISSUE
SG11201502713QA (en) * 2012-10-08 2015-05-28 Cormatrix Cardiovascular Inc Compositions, structures and methods for neural regeneration
EP3659633A1 (en) 2013-02-06 2020-06-03 LifeCell Corporation Methods for localized modification of tissue products
WO2014133541A2 (en) * 2013-03-01 2014-09-04 Cormatrix Cardiovascular, Inc. Method and system for treatment of cardiovascular disorders
EP2797556B1 (en) * 2013-03-01 2018-08-01 Cormatrix Cardiovascular, Inc. Anchored cardiovascular valve
CA2907774C (en) * 2013-04-08 2022-11-01 Asana Medical, Inc. Method and composition for treating inflammatory bowel disease without colectomy
US20140330373A1 (en) * 2013-05-03 2014-11-06 Robert G. Matheny Reinforced Prosthetic Tissue Valves
US10307510B2 (en) 2013-11-04 2019-06-04 Lifecell Corporation Methods of removing alpha-galactose
EP3119448B1 (en) 2014-03-21 2020-04-22 University of Pittsburgh- Of the Commonwealth System of Higher Education Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
US20210236277A1 (en) * 2014-03-29 2021-08-05 Cormatrix Cardiovascular, Inc. Prosthetic Heart Valves
US9238090B1 (en) * 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
CN104587528A (zh) * 2014-12-26 2015-05-06 上海交通大学医学院附属仁济医院 人心脏瓣膜组织脱细胞基质及其制备和应用
WO2017034600A1 (en) 2015-08-21 2017-03-02 Cormatrix Cardiovascular, Inc. Extracellular matrix prostheses for treating damaged biological tissue
EP3402876B1 (en) 2016-01-13 2021-10-13 University of Pittsburgh- Of the Commonwealth System of Higher Education Vascular extracellular matrix hydrogel
AU2017274190A1 (en) 2016-06-03 2018-12-13 Lifecell Corporation Methods for localized modification of tissue products
EP3481446B1 (en) 2016-07-05 2020-09-30 LifeCell Corporation Tissue matrices incorporating multiple tissue types
WO2018056018A1 (ja) * 2016-09-21 2018-03-29 グンゼ株式会社 ヘパリンを含有する生体吸収性高分子からなる多孔質基材の製造方法、ヘパリンを含有する生体吸収性高分子からなる多孔質基材、及び、人工血管
US11045583B2 (en) 2016-12-22 2021-06-29 Lifecell Corporation Devices and methods for tissue cryomilling
WO2018140853A1 (en) 2017-01-30 2018-08-02 Lifecell Corporation Transglutaminase treated products
WO2018140854A1 (en) 2017-01-30 2018-08-02 Lifecell Corporation Tissue matrix materials and enzymatic adhesives
CA3050733A1 (en) 2017-01-30 2018-08-02 Lifecell Corporation Devices including muscle matrix and methods of production and use
CA3098149A1 (en) * 2018-05-03 2019-11-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Matrix bound vesicles (mbvs) containing il-33 and their use
CN117177783A (zh) * 2020-12-23 2023-12-05 布朗大学 脱细胞哺乳动物胞外基质碎片，其制备方法和使用方法

Family Cites Families (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535483A (en) * 1983-01-17 1985-08-20 Hemex, Inc. Suture rings for heart valves
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
DE4125400C2 (de) 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US6653291B1 (en) 1992-11-13 2003-11-25 Purdue Research Foundation Composition and method for production of transformed cells
US5352463A (en) 1992-11-13 1994-10-04 Badylak Steven F Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor
US5641518A (en) * 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5480424A (en) * 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5713950A (en) * 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US6475232B1 (en) 1996-12-10 2002-11-05 Purdue Research Foundation Stent with reduced thrombogenicity
ATE310839T1 (de) * 1994-04-29 2005-12-15 Scimed Life Systems Inc Stent mit kollagen
US5695998A (en) * 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
JPH11508151A (ja) * 1995-04-07 1999-07-21 パーデュー・リサーチ・ファウンデーション 膀胱再建方法及び膀胱再建用組織グラフト
US5711969A (en) 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5755791A (en) 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US8716227B2 (en) 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
EP1378257B1 (en) * 1996-08-23 2008-05-14 Cook Biotech, Inc. Collagen-based graft prosthesis
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
DK0925067T3 (da) * 1996-09-16 2004-05-03 Purdue Research Foundation Graft fra submucosavæv til reparation af neurologisk væv
CA2267449C (en) 1996-11-05 2008-10-14 Purdue Research Foundation Myocardial graft constructs
ES2263185T3 (es) * 1996-12-10 2006-12-01 Purdue Research Foundation Biomaterial derivado de tejido hepatico de vertebrados.
US6696270B2 (en) * 1996-12-10 2004-02-24 Purdue Research Foundation Gastric submucosal tissue as a novel diagnostic tool
WO1998025964A1 (en) * 1996-12-10 1998-06-18 Purdue Research Foundation Submucosa extracts
SK71399A3 (en) * 1996-12-10 2000-05-16 Purdue Research Foundation Tubular submucosal graft constructs
DE69734218T2 (de) 1996-12-10 2006-07-06 Purdue Research Foundation, West Lafayette Gewebetransplantat aus der Magensubmukosa
JP2001515706A (ja) 1997-09-11 2001-09-25 パーデュー・リサーチ・ファウンデーション ガラクトシダーゼ変性粘膜下組織
US6045576A (en) * 1997-09-16 2000-04-04 Baxter International Inc. Sewing ring having increased annular coaptation
US6264992B1 (en) 1998-02-27 2001-07-24 Purdue Research Foundation Submucosa as a growth substrate for cells
US7452371B2 (en) * 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
US6254636B1 (en) * 1998-06-26 2001-07-03 St. Jude Medical, Inc. Single suture biological tissue aortic stentless valve
AU771367B2 (en) 1998-08-20 2004-03-18 Cook Medical Technologies Llc Coated implantable medical device
WO2000032250A1 (en) 1998-12-01 2000-06-08 Cook Biotech, Inc. A multi-formed collagenous biomaterial medical device
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6918396B1 (en) * 1998-12-01 2005-07-19 Purdue Research Foundation Method for vocal cord reconstruction
DE60040839D1 (de) * 1999-01-26 2009-01-02 Edwards Lifesciences Corp Messschablonen für anatomische öffnungen
US20030096740A1 (en) * 1999-03-10 2003-05-22 Lars Hammarstrom Matrix protein compositions for induction of apoptosis
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
US20040043006A1 (en) * 2002-08-27 2004-03-04 Badylak Stephen F. Tissue regenerative composition
US6579538B1 (en) 1999-12-22 2003-06-17 Acell, Inc. Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
PL211544B1 (pl) * 2000-01-31 2012-05-31 Cook Biotech Inc Zespół zastawki stentu i zastosowanie zespołu zastawki stentu
US7033611B2 (en) * 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
US20030009145A1 (en) * 2001-03-23 2003-01-09 Struijker-Boudier Harry A.J. Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
US6733525B2 (en) * 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
ATE272369T1 (de) 2001-03-27 2004-08-15 Cook William Europ Gefässtransplantat für die aorta
CA2452033C (en) * 2001-06-28 2011-11-08 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
US6706069B2 (en) * 2001-09-13 2004-03-16 J. Lee Berger Spinal grooved director with built in balloon
US6726715B2 (en) * 2001-10-23 2004-04-27 Childrens Medical Center Corporation Fiber-reinforced heart valve prosthesis
ATE390151T1 (de) 2001-10-26 2008-04-15 Cook Biotech Inc Medizinisches implantat mit netzartiger struktur
AU2002364514B2 (en) * 2001-11-29 2008-12-18 Cook Medical Technologies Llc Medical device delivery system
JP3782748B2 (ja) * 2002-03-29 2006-06-07 株式会社ジェイテクト 車両のステアリング装置
AU2003231248B2 (en) 2002-05-02 2009-03-05 Purdue Research Foundation Vascularization enhanced graft constructs
US9492267B2 (en) 2002-05-02 2016-11-15 Cook Biotech Incorporated Cell-seeded extracellular matrix grafts
EP1503652A4 (en) 2002-05-02 2006-02-08 Purdue Research Foundation HYBRID GRAFTS WITH IMPROVED VASCULARIZATION
NZ536564A (en) 2002-05-02 2008-05-30 Purdue Research Foundation Vascularization enhanced graft constructs which comprise a matrix composition consisting of liver basement membrane
US20040187877A1 (en) 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of liver tissue
US20040191226A1 (en) 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of body wall
WO2004080352A1 (en) 2003-03-12 2004-09-23 Cook Incorporated Prosthetic valve that permits retrograde flow
US7530995B2 (en) 2003-04-17 2009-05-12 3F Therapeutics, Inc. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US8221492B2 (en) * 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
EP2314327B2 (en) * 2003-05-05 2017-09-20 Ben-Gurion University Of The Negev Research And Development Authority Injectable cross-linked polymeric preparations and uses thereof
ATE481057T1 (de) * 2003-05-28 2010-10-15 Cook Inc Ventilprothese mit gefässbefestigungsvorrichtung
EP1638548B1 (en) * 2003-06-18 2010-09-29 Institut de Cardiologie de Montreal / Montréal Heart Institute Preventing atrial fibrillation (af) with the use of statin drugs
US8974730B2 (en) * 2003-06-23 2015-03-10 Novasterilis, Inc. Process for creating acellular viable donor soft tissue
US7108832B2 (en) 2003-06-23 2006-09-19 Novasterilis Inc. Sterialization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
WO2005011535A2 (en) * 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
US7153324B2 (en) 2003-07-31 2006-12-26 Cook Incorporated Prosthetic valve devices and methods of making such devices
US8741352B2 (en) * 2003-08-25 2014-06-03 Cook Biotech Incorporated Graft materials containing ECM components, and methods for their manufacture
DE112004001553T5 (de) * 2003-08-25 2006-08-10 Cook Biotech, Inc., West Lafayette Verpflanzungsmaterialien, die bioaktive Substanzen enthalten, und Methoden zu deren Herstellung
GB2423934B (en) 2003-09-04 2007-11-28 Cook Biotech Inc Extracellular matrix composite materials, and manufacture and use thereof
PE20050438A1 (es) * 2003-10-20 2005-06-14 Esperion Therapeutics Inc Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos
WO2005046447A2 (en) * 2003-11-10 2005-05-26 Symphony Medical, Inc. Method to control ventricular rate in atrial fibrillation patients
CA2554460A1 (en) * 2004-02-09 2005-08-25 Cook Biotech Incorporated Stent graft devices having collagen coating
CA2560876A1 (en) * 2004-03-29 2005-10-13 Cook Biotech Incorporated Medical graft products with differing regions and methods and systems for producing the same
CA2565203A1 (en) 2004-03-31 2005-10-20 Cook Incorporated Ecm-based graft material
EP1729677B1 (en) * 2004-03-31 2010-04-21 Cook Incorporated Graft material and stent graft comprising extracellular collagen matrix and method of preparation
WO2006015287A2 (en) * 2004-07-30 2006-02-09 Cook Biotech Incorporated Graft with increased resistance to enzymatic degradation
EP1807023A1 (en) * 2004-09-10 2007-07-18 Cook Incorporated Prosthetic valve with pores
UA88321C2 (ru) 2004-09-30 2009-10-12 Ковалон Текнолоджиз Инк. Неадгезивные эластичные желатиновые матрицы
CA2583938A1 (en) * 2004-10-06 2006-04-20 Cook Incorporated Medical device with bioactive agent
AU2005295737A1 (en) 2004-10-15 2006-04-27 Cook Biotech Incorporated Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof
US7563276B2 (en) * 2004-10-29 2009-07-21 Cook Incorporated Intraluminal medical device with cannula for controlled retrograde flow
US8874204B2 (en) * 2004-12-20 2014-10-28 Cardiac Pacemakers, Inc. Implantable medical devices comprising isolated extracellular matrix
US9138445B2 (en) 2005-03-09 2015-09-22 Cook Biotech Incorporated Medical graft materials with adherent extracellular matrix fibrous mass
US8454678B2 (en) 2005-03-19 2013-06-04 Cook Biotech Incorporated Prosthetic implants including ECM composite material
EP1863402B1 (en) * 2005-03-24 2010-01-13 Cook Incorporated Exchangeable delivery system with distal protection
US8197534B2 (en) 2005-03-31 2012-06-12 Cook Medical Technologies Llc Valve device with inflatable chamber
US20060259128A1 (en) 2005-04-18 2006-11-16 Cook Incorporated Method for implanting prosthetic valves
US20060251702A1 (en) 2005-05-05 2006-11-09 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
AU2006247317B2 (en) * 2005-05-16 2012-04-05 Purdue Research Foundation Engineered extracellular matrices
US20070014869A1 (en) * 2005-07-15 2007-01-18 Cormatrix Cardiovascular, Inc. Compositions for reconstruction, replacement or repair of intracardiac tissue
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
US9072816B2 (en) * 2006-01-18 2015-07-07 Cormatrix Cardiovascular, Inc. Composition for modulating inflammation of cardiovascular tissue
US20070014868A1 (en) * 2005-07-15 2007-01-18 Cormatrix Cardiovascular, Inc. Patch for reconstruction, replacement or repair of the pericardial sac
US20080279939A1 (en) * 2007-05-10 2008-11-13 Firestone Leigh H Extracellular matrix compositions for tissue regeneration
WO2007011644A2 (en) 2005-07-15 2007-01-25 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent tissue
US7815923B2 (en) 2005-12-29 2010-10-19 Cook Biotech Incorporated Implantable graft material
US9532943B2 (en) * 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
US20080046070A1 (en) * 2006-03-31 2008-02-21 Obermiller F J Chemically treated extracellular matrices for affecting the cellular response
US20070269476A1 (en) 2006-05-16 2007-11-22 Voytik-Harbin Sherry L Engineered extracellular matrices control stem cell behavior
EP3400908B1 (en) 2006-05-30 2020-06-17 Cook Medical Technologies LLC Artificial valve prosthesis
WO2008101083A2 (en) * 2007-02-15 2008-08-21 Cook Incorporated Artificial valve prostheses with a free leaflet portion
ATE528025T1 (de) 2007-04-27 2011-10-15 Cook Biotech Inc Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US9034367B2 (en) 2007-05-10 2015-05-19 Cormatrix Cardiovascular, Inc. Articles for tissue regeneration with biodegradable polymer
US20080281419A1 (en) 2007-05-10 2008-11-13 Matheny Robert G Breast implants and compositions of extracellular matrix
US8403979B2 (en) 2007-05-17 2013-03-26 Cook Medical Technologies Llc Monocuspid prosthetic valve having a partial sinus
WO2008151040A2 (en) 2007-05-31 2008-12-11 Cook Biotech Incorporated Analgesic coated medical product
US8715337B2 (en) * 2007-11-09 2014-05-06 Cook Medical Technologies Llc Aortic valve stent graft
EP2222247B1 (en) * 2007-11-19 2012-08-22 Cook Medical Technologies LLC Valve frame
WO2009076391A2 (en) 2007-12-10 2009-06-18 Cook Biotech Incorporated Medical materials including modified extracellular matrix materials
US20090157177A1 (en) * 2007-12-18 2009-06-18 Matheny Robert G Sewing Ring for a Prosthetic Tissue Valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US20090157170A1 (en) * 2007-12-18 2009-06-18 Matheny Robert G Trileaflet Semi-Lunar Prosthetic Tissue Valve
US7854759B2 (en) 2007-12-21 2010-12-21 Cook Incorporated Prosthetic flow modifying device
WO2009126783A1 (en) 2008-04-09 2009-10-15 Cook Incorporated Loading apparatus and method for expandable intraluminal medical devices
WO2009149215A1 (en) 2008-06-05 2009-12-10 Arbor Surgical Technologies, Inc. Connection systems for two piece prosthetic heart valve assemblies and methods for making and using them
WO2010011878A2 (en) * 2008-07-24 2010-01-28 Cook Incorporated Valve device with biased leaflets
US20120027807A1 (en) * 2008-10-09 2012-02-02 The General Hospital Corporation Tissue engineered myocardium and methods of production and uses thereof
US8808365B2 (en) * 2009-01-07 2014-08-19 Martin Kean Chong Ng Chemically and biologically modified medical devices
US8980296B2 (en) 2009-02-18 2015-03-17 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US8877224B2 (en) * 2009-02-18 2014-11-04 Cormatrix Cardiovascular, Inc Compositions for preventing cardiac arrhythmia
SG10201506909PA (en) * 2010-09-01 2015-10-29 Genzyme Corp Treatment of myocardial infarction using tgf - beta antagonists

Also Published As

Publication number Publication date
KR20120033299A (ko) 2012-04-06
US20150157764A1 (en) 2015-06-11
US20150164959A1 (en) 2015-06-18
EP2398502A1 (en) 2011-12-28
US8980296B2 (en) 2015-03-17
US20150150913A1 (en) 2015-06-04
US20150164960A1 (en) 2015-06-18
US9446078B2 (en) 2016-09-20
ES2553762T3 (es) 2015-12-11
EP2398502A4 (en) 2012-12-26
US9308225B2 (en) 2016-04-12
HK1165332A1 (en) 2012-10-05
EP2398502B1 (en) 2015-11-04
US20150196605A1 (en) 2015-07-16
US9089549B2 (en) 2015-07-28
US20140377217A1 (en) 2014-12-25
US9078882B2 (en) 2015-07-14
US20100233235A1 (en) 2010-09-16
EP3000472A1 (en) 2016-03-30
US9119841B2 (en) 2015-09-01
IL214706A0 (en) 2011-11-30
JP2012518041A (ja) 2012-08-09
PL3000472T3 (pl) 2017-09-29
AU2010216095A1 (en) 2011-09-22
US20150150914A1 (en) 2015-06-04
CN102395381A (zh) 2012-03-28
WO2010096458A1 (en) 2010-08-26
EP3000472B1 (en) 2017-04-19
CA2752899A1 (en) 2010-08-26
DK2398502T3 (en) 2015-11-23
MX2011008735A (es) 2012-01-12
ZA201106165B (en) 2013-10-30
AU2010216095B2 (en) 2015-10-08
US9084841B2 (en) 2015-07-21
US9078873B2 (en) 2015-07-14
BRPI1008628A2 (pt) 2016-03-01
IL214706A (en) 2016-07-31

Similar Documents

Publication Publication Date Title
HK1165332A1 (en) Compositions and methods for preventing cardiac arrhythmia
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
EP2542060A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
AP3106A (en) Antiparisitic dihydroazole compounds and compositions comprising same
ZA201200054B (en) Therapeutic compounds and compositions
SI3812360T1 (sl) Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo
IL229285B (en) The trains and methods to prevent heart rhythm disturbance
ZA201102765B (en) Process for extracting cardiac glycodides and compositions
IL218212A0 (en) Therapeutic methods and compositions
EP2629742A4 (en) HAIR CARE COMPOSITIONS AND RELATED METHODS
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
HK1254495A1 (zh) 舒巴林用於治療心房纖顫的用途
LT2437606T (lt) Kompozicijos ir būdai skirti didinti telomerazės aktyvumą
GB0903299D0 (en) Composition and methods
EP2642854A4 (en) FUNGICIDE COMPOSITIONS AND METHOD
GB0901494D0 (en) Compositions and Methods
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
GB0904743D0 (en) Methods and compositions for modulating cardiac contractility
ZA201008384B (en) Lasalocid compositions and methods
GB0909720D0 (en) Compositions and methods
GB0903913D0 (en) Compositions and methods
GB0907616D0 (en) Methods and compositions
GB0908498D0 (en) Compositions and methods
GB0907093D0 (en) Tissue softening methods and compositions